Question Everything. See who's reporting it.

mRNA Cancer Drug Shows Positive Results in Major Trial

Source: The Straits Times

The story in brief

Moderna and Merck announced positive results from a large, late-stage trial for the mRNA-based drug intismeran autogene, which targets melanoma by analyzing a patient's tumor. The breakthrough, the first of its kind for an mRNA cancer drug, sent Moderna's stock up 145% and Merck's up 12%. The treatment uses mRNA technology similar to that in Covid-19 vaccines, offering personalized cancer therapy.

2 outletsSee what the other 1 outlet said

NEWXFree on Android and iPhone. Open in NEWX